Suppr超能文献

亚洲阿尔茨海默病及其他痴呆症的现状、趋势和挑战(1990 - 2036年)

The current status, trends, and challenges of Alzheimer's disease and other dementias in Asia (1990-2036).

作者信息

He Ziyang, Zhang Haoqin, Hu Guishan, Qiao Yinan, Yin Can, Li Jianqiao, Lin Hong, Wu Anguo, Qin Dalian, Law Betty Yuen-Kwan, Hu Guangqiang, Yu Lu

机构信息

Sichuan Key Medical Laboratory of New Drug Discovery and Druggability Evaluation, School of Pharmacy, Southwest Medical University, Luzhou, China.

Clinic Medical College, Southwest Medical University, Luzhou, China.

出版信息

Front Public Health. 2025 Jun 10;13:1583339. doi: 10.3389/fpubh.2025.1583339. eCollection 2025.

Abstract

BACKGROUND

With global aging, Alzheimer's disease (AD) and other dementias have emerged as significant health threats to the older adults, garnering considerable attention due to their impact on public health. Despite the substantial burden of dementia in Asia, targeted research remains limited. This study aims to assess the current burden, future trends, risk factors, and inequalities in Asia.

METHOD

The GBD 2021 study was utilized to evaluate the numbers and age-standardized rates (ASRs) of prevalence, mortality, and disability-adjusted life-years (DALYs) of AD and other dementias from 1990 to 2021. Joinpoint regression analysis was performed to assess the trends during this period, while the Autoregressive Integrated Moving Average (ARIMA) model was employed to predict future trends. Additionally, the relationship between disease burden and sociodemographic index (SDI) was also analyzed.

RESULTS

In 2021, Asia experienced a 250.44% increase in prevalent cases, a 297.34% rise in mortality, and a 249.54% surge in DALYs for AD and other dementias compared to 1990. Meanwhile, the age-standardized prevalence rate, age-standardized mortality rate, and age-standardized DALY rate also exhibited varying degrees of rise from 1990 to 2021. Demographically, the disease burden was higher in women and those aged 65 and above. Regionally, the burden was highest in East Asia and relatively low in South and Central Asia. Nationally, China, India, Japan, and Indonesia reported the most cases. Over the next 15 years, the age-standardized prevalence rate in Asia is expected to peak in 2028 before declining, while the age-standardized mortality rate is anticipated to keep rising. An overall "V" shaped association was found between sociodemographic index (SDI) and the age-standardized DALY rate in Asia. Only smoking, high fasting plasma glucose (FPG), and high BMI were identified as causal risk factors within the GBD framework.

CONCLUSION

The burden of AD and other dementias in Asia has significantly increased over the past three decades and is expected to persistently impact Asian populations, particularly in developing countries experiencing rapid demographic shifts. Women and the older adult should be a focus of attention. It is imperative to implement targeted prevention and intervention strategies, enhance chronic disease management, and control risk factors.

摘要

背景

随着全球老龄化,阿尔茨海默病(AD)和其他痴呆症已成为对老年人的重大健康威胁,因其对公众健康的影响而备受关注。尽管亚洲痴呆症负担沉重,但针对性研究仍然有限。本研究旨在评估亚洲当前的负担、未来趋势、风险因素和不平等情况。

方法

利用全球疾病负担研究(GBD)2021来评估1990年至2021年AD和其他痴呆症的患病率、死亡率及伤残调整生命年(DALY)的数量和年龄标准化率(ASR)。进行Joinpoint回归分析以评估该期间的趋势,同时采用自回归积分移动平均(ARIMA)模型预测未来趋势。此外,还分析了疾病负担与社会人口指数(SDI)之间的关系。

结果

与1990年相比,2021年亚洲AD和其他痴呆症的患病率病例增加了250.44%,死亡率上升了297.34%,DALY增加了249.54%。同时,1990年至2021年期间,年龄标准化患病率、年龄标准化死亡率和年龄标准化DALY率也呈现出不同程度的上升。从人口统计学角度来看,女性和65岁及以上人群的疾病负担更高。在区域方面,东亚的负担最高,南亚和中亚相对较低。在国家层面,中国、印度、日本和印度尼西亚报告的病例最多。在未来15年里,亚洲的年龄标准化患病率预计将在2028年达到峰值后下降,而年龄标准化死亡率预计将持续上升。在亚洲,社会人口指数(SDI)与年龄标准化DALY率之间总体呈“V”形关联。在GBD框架内,仅吸烟、高空腹血糖(FPG)和高体重指数被确定为因果风险因素。

结论

在过去三十年中,亚洲AD和其他痴呆症的负担显著增加,预计将持续影响亚洲人群,尤其是在经历快速人口结构变化的发展中国家。女性和老年人应成为关注焦点。必须实施有针对性的预防和干预策略,加强慢性病管理并控制风险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c3e/12185285/96746274247c/fpubh-13-1583339-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验